Key result
A 3-month polyunsaturated fatty acid-rich diet in women with PCOS increased fasting glucose from 76 to /dl compared to a habitual diet.
Why the study?
Does a PUFA-rich diet alter metabolic and endocrine parameters in patients with polycystic ovary syndrome?
Does a PUFA-rich diet alter metabolic and endocrine parameters in patients with polycystic ovary syndrome?
Increased dietary PUFA intake exerts significant metabolic and endocrine effects in women with PCOS, including an unexpected increase in fasting glucose.
Answers are grounded in this paper and cite their sources.
May warrant caution with PUFA-rich diets in PCOS; leaves open effects on glycemic control.
Effects of a polyunsaturated fatty acid (PUFA)-rich diet were investigated in 17 polycystic ovary syndrome (PCOS) patients. After a 3-month habitual diet period, dietary fats were partly replaced with PUFAs for another 3 months. The PUFA-rich diet increased plasma linoleic acid from 28.36 +/- 1.00% to 33.76 +/- 1.08% (P < 0.002) and alpha-linolenic acid from 0.52 +/- 0.03% to 1.06 +/- 0.10% (P < 0.0001). Fasting glucose increased from 76 +/- 3 to 95 +/- 3 mg/dl (4.2 +/- 0.2 to 5.30.2 mmol/liter; P < 0.0001), and the area under the curve for glucose during oral glucose tolerance test increased from 421 +/- 34 to 503 +/- 31 mg/dl (23.4 +/- 1.9 to 27.9 +/- 1.7 mmol/liter; P < 0.001). Plasma insulin did not change either at fasting or during oral glucose tolerance test. Fasting plasma free fatty acids decreased from 0.596 +/- 0.048 to 0.445 +/- 0.058 mg/dl (P = 0.037), and ketone bodies decreased from 9.14 +/- 1.57 to 3.63 +/- 0.62 mg/dl (895 +/- 154 to 356 +/- 61 micromol/liter; P < 0.003). Plasma 15-deoxyprostaglandin J(2) tended to decrease (from 239 +/- 65 to 171 +/- 60 ng/ml; P = 0.053). Plasma testosterone, free testosterone, SHBG, dehydroepiandrosterone sulfate, LH, FSH, and urinary estrogen conjugates did not change. Urinary pregnanediol 3-glucuronide increased from 18.6 +/- 2.2 to 31.0 +/- 5.7 micro g/mg creatinine (P = 0.038). In conclusion, increased dietary PUFA intake can exert significant metabolic and endocrine effects in women with PCOS.
No takes yet. Share an insight, caveat, or question.
Kasim-Karakas et al. (2004) studied Polycystic ovary syndrome (PCOS) (n=17). Polyunsaturated fatty acid (PUFA)-rich diet vs. Habitual diet was evaluated on Fasting glucose (mg/dl) (p=<0.0001). A 3-month polyunsaturated fatty acid-rich diet in women with PCOS increased fasting glucose from 76 to /dl compared to a habitual diet.
Synapse has enriched 10 related papers. Consider them for comparative context: